- Home
- ASDP Case Study Submission Gallery
- 17-month-old male with multiple subcutaneous nodules and pancytopenia
Interactive Case Study - September 2026









1. Patterson JW. Weedon's Skin Pathology. 6th ed. Philadephia: Elsevier; 2025.
2. Arber DA BM, Cook JR, et al. The international consensus classification of myeloid and lymphoid neoplasms. Philadelphia: Wolters Kluwer; 2025.
3. World Health Organization. Haematolymphoid tumours. 5th edition. ed. Lyon: International Agency for Research on Cancer; 2024.
4. Goodlad JR. Updated Classification of Cutaneous Lymphoma. Adv Anat Pathol. 2025;32(3):239-255.
5. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838-845.
6. Michonneau D, Petrella T, Ortonne N, et al. Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy. Acta Derm Venereol. 2017;97(3):358-364.
7. Gayden T, Sepulveda FE, Khuong-Quang DA, et al. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018;50(12):1650-1657.
8. Polprasert C, Takeuchi Y, Kakiuchi N, et al. Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood Adv. 2019;3(4):588-595.
9. Sonigo G, Battistella M, Beylot-Barry M, et al. HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. Blood. 2020;135(13):1058-1061.
10. Koh J, Jang I, Mun S, et al. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021;5(20):3919-3930.
11. Moonla C, Polprasert C, Komvilaisak P, et al. Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis. Haematologica. 2023;108(10):2743-2752.
12. Li Z, Lu L, Zhou Z, et al. Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma. Br J Haematol. 2018;181(3):406-410.
Acknowledgements
Author Profiles
Angela M. B. Collie, MD, PhD
Mayo Clinic
Angela Collie is a hematopathologist at Mayo Clinic in Rochester, Minnesota. She attended the University of Washington for her M.D. and Ph.D. as a part of the Medical Scientist Training Program before completing AP/CP residency, hematopathology fellowship and dermatopathology fellowship at Cleveland Clinic. With her subspecialty training in both dermatopathology and hematopathology, she has a particular interest in lymphoma and all types of cutaneous hematopoietic disorders.
Kathryn E. Yunk
Denison University
K. Emily Yunk is an undergraduate student at Denison University. She is studying biochemistry on the pre-medicine path. Emily is interested in dermatology and pathology and learning more about both fields.
Question:
17-month-old male with multiple subcutaneous nodules and pancytopenia
Category
Tumors > Lymphomatous/Leukemic Infiltrates
Description